{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T11:15:31Z","timestamp":1788347731139,"version":"build-2803163510"},"reference-count":87,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,12,7]],"date-time":"2020-12-07T00:00:00Z","timestamp":1607299200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009657","name":"FSHD Global Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009657","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000069","name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy - Methods & Clinical Development"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1016\/j.omtm.2020.12.001","type":"journal-article","created":{"date-parts":[[2020,12,10]],"date-time":"2020-12-10T05:49:27Z","timestamp":1607579367000},"page":"298-311","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":55,"special_numbering":"C","title":["Targeted epigenetic repression by CRISPR\/dSaCas9 suppresses pathogenic DUX4-fl expression in FSHD"],"prefix":"10.1016","volume":"20","author":[{"given":"Charis L.","family":"Himeda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takako I.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter L.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.omtm.2020.12.001_bib1","series-title":"Facioscapulohumeral Disease. Thesis","first-page":"243","author":"Padberg","year":"1982"},{"key":"10.1016\/j.omtm.2020.12.001_bib2","series-title":"Prevalence and incidence of rare diseases: Bibliographic data","author":"Orphanet","year":"2018"},{"key":"10.1016\/j.omtm.2020.12.001_bib3","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/ng1262","article-title":"Hypomethylation of D4Z4 in 4q-linked and non-4q-linked facioscapulohumeral muscular dystrophy","volume":"35","author":"van Overveld","year":"2003","journal-title":"Nat. Genet."},{"key":"10.1016\/j.omtm.2020.12.001_bib4","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1146\/annurev-genom-083118-014933","article-title":"The Genetics and Epigenetics of Facioscapulohumeral Muscular Dystrophy","volume":"20","author":"Himeda","year":"2019","journal-title":"Annu. Rev. Genomics Hum. Genet."},{"key":"10.1016\/j.omtm.2020.12.001_bib5","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/0140-6736(90)92148-B","article-title":"Location of facioscapulohumeral muscular dystrophy gene on chromosome 4","volume":"336","author":"Wijmenga","year":"1990","journal-title":"Lancet"},{"key":"10.1016\/j.omtm.2020.12.001_bib6","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1038\/ng0992-26","article-title":"Chromosome 4q DNA rearrangements associated with facioscapulohumeral muscular dystrophy","volume":"2","author":"Wijmenga","year":"1992","journal-title":"Nat. Genet."},{"key":"10.1016\/j.omtm.2020.12.001_bib7","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1093\/hmg\/2.12.2037","article-title":"FSHD associated DNA rearrangements are due to deletions of integral copies of a 3.2 kb tandemly repeated unit","volume":"2","author":"van Deutekom","year":"1993","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.omtm.2020.12.001_bib8","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1038\/ng.2454","article-title":"Digenic inheritance of an SMCHD1 mutation and an FSHD-permissive D4Z4 allele causes facioscapulohumeral muscular dystrophy type 2","volume":"44","author":"Lemmers","year":"2012","journal-title":"Nat. Genet."},{"key":"10.1016\/j.omtm.2020.12.001_bib9","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1016\/j.ajhg.2016.03.013","article-title":"Mutations in DNMT3B Modify Epigenetic Repression of the D4Z4 Repeat and the Penetrance of Facioscapulohumeral Dystrophy","volume":"98","author":"van den Boogaard","year":"2016","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.omtm.2020.12.001_bib10","doi-asserted-by":"crossref","first-page":"e1001181","DOI":"10.1371\/journal.pgen.1001181","article-title":"Facioscapulohumeral dystrophy: incomplete suppression of a retrotransposed gene","volume":"6","author":"Snider","year":"2010","journal-title":"PLoS Genet."},{"key":"10.1016\/j.omtm.2020.12.001_bib11","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1111\/j.1582-4934.2012.01647.x","article-title":"DUX4 expression in FSHD muscle cells: how could such a rare protein cause a myopathy?","volume":"17","author":"Tassin","year":"2013","journal-title":"J.\u00a0Cell. Mol. Med."},{"issue":"R2","key":"10.1016\/j.omtm.2020.12.001_bib12","doi-asserted-by":"crossref","first-page":"R153","DOI":"10.1093\/hmg\/ddy162","article-title":"Facioscapulohumeral dystrophy: activating an early embryonic transcriptional program in human skeletal muscle","volume":"27","author":"Campbell","year":"2018","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.omtm.2020.12.001_bib13","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1126\/science.1189044","article-title":"A unifying genetic model for facioscapulohumeral muscular dystrophy","volume":"329","author":"Lemmers","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.omtm.2020.12.001_bib14","doi-asserted-by":"crossref","first-page":"5342","DOI":"10.1093\/hmg\/ddu251","article-title":"DUX4-induced gene expression is the major molecular signature in FSHD skeletal muscle","volume":"23","author":"Yao","year":"2014","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.omtm.2020.12.001_bib15","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1038\/mt.2015.200","article-title":"CRISPR\/dCas9-mediated Transcriptional Inhibition Ameliorates the Epigenetic Dysregulation at D4Z4 and Represses DUX4-fl in FSH Muscular Dystrophy","volume":"24","author":"Himeda","year":"2016","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2020.12.001_bib16","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1016\/j.ymthe.2018.04.019","article-title":"Identification of Epigenetic Regulators of DUX4-fl for Targeted Therapy of Facioscapulohumeral Muscular Dystrophy","volume":"26","author":"Himeda","year":"2018","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2020.12.001_bib17","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1038\/mt.2012.68","article-title":"RNA interference inhibits DUX4-induced muscle toxicity in\u00a0vivo: implications for a targeted FSHD therapy","volume":"20","author":"Wallace","year":"2012","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2020.12.001_bib18","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1093\/hmg\/ddw015","article-title":"Antisense targeting of 3\u2032 end elements involved in DUX4 mRNA processing is an efficient therapeutic strategy for facioscapulohumeral dystrophy: a new gene-silencing approach","volume":"25","author":"Marsollier","year":"2016","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.omtm.2020.12.001_bib19","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1177\/1087057116651868","article-title":"Transcriptional Inhibitors Identified in a 160,000-Compound Small-Molecule DUX4 Viability Screen","volume":"21","author":"Choi","year":"2016","journal-title":"J.\u00a0Biomol. Screen."},{"key":"10.1016\/j.omtm.2020.12.001_bib20","doi-asserted-by":"crossref","first-page":"11837","DOI":"10.1074\/jbc.RA118.002633","article-title":"Protein kinase A activation inhibits DUX4 gene expression in myotubes from patients with facioscapulohumeral muscular dystrophy","volume":"293","author":"Cruz","year":"2018","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.omtm.2020.12.001_bib21","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s13395-017-0134-x","article-title":"BET bromodomain inhibitors and agonists of the beta-2 adrenergic receptor identified in screens for compounds that inhibit DUX4 expression in FSHD muscle cells","volume":"7","author":"Campbell","year":"2017","journal-title":"Skelet. Muscle"},{"key":"10.1016\/j.omtm.2020.12.001_bib22","doi-asserted-by":"crossref","first-page":"4419","DOI":"10.1093\/hmg\/dds284","article-title":"Facioscapulohumeral muscular dystrophy family studies of DUX4 expression: evidence for disease modifiers and a quantitative model of pathogenesis","volume":"21","author":"Jones","year":"2012","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.omtm.2020.12.001_bib23","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s13148-015-0072-6","article-title":"Individual epigenetic status of the pathogenic D4Z4 macrosatellite correlates with disease in facioscapulohumeral muscular dystrophy","volume":"7","author":"Jones","year":"2015","journal-title":"Clin. Epigenetics"},{"key":"10.1016\/j.omtm.2020.12.001_bib24","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1093\/hmg\/ddy364","article-title":"MRI-informed muscle biopsies correlate MRI with pathology and DUX4 target gene expression in FSHD","volume":"28","author":"Wang","year":"2019","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.omtm.2020.12.001_bib25","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1124\/jpet.119.259663","article-title":"Clinically Advanced p38 Inhibitors Suppress DUX4 Expression in Cellular and Animal Models of Facioscapulohumeral Muscular Dystrophy","volume":"370","author":"Oliva","year":"2019","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.omtm.2020.12.001_bib26","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1124\/jpet.119.264689","article-title":"p38\u03b1 Regulates Expression of DUX4 in a Model of Facioscapulohumeral Muscular Dystrophy","volume":"374","author":"Rojas","year":"2020","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.omtm.2020.12.001_bib27","doi-asserted-by":"crossref","first-page":"91","DOI":"10.3389\/fcell.2016.00091","article-title":"Regulation of Muscle Stem Cell Functions: A Focus on the p38 MAPK Signaling Pathway","volume":"4","author":"Segal\u00e9s","year":"2016","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.omtm.2020.12.001_bib28","doi-asserted-by":"crossref","first-page":"eaay9648","DOI":"10.1126\/scitranslmed.aay9648","article-title":"Efficacy and costs of spinal muscular atrophy drugs","volume":"12","author":"Darrow","year":"2020","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.omtm.2020.12.001_bib29","doi-asserted-by":"crossref","first-page":"e1000559","DOI":"10.1371\/journal.pgen.1000559","article-title":"Specific loss of histone H3 lysine 9 trimethylation and HP1gamma\/cohesin binding at D4Z4 repeats is associated with facioscapulohumeral dystrophy (FSHD)","volume":"5","author":"Zeng","year":"2009","journal-title":"PLoS Genet."},{"key":"10.1016\/j.omtm.2020.12.001_bib30","doi-asserted-by":"crossref","first-page":"579","DOI":"10.4161\/epi.20001","article-title":"Correlation analysis of clinical parameters with epigenetic modifications in the DUX4 promoter in FSHD","volume":"7","author":"Balog","year":"2012","journal-title":"Epigenetics"},{"key":"10.1016\/j.omtm.2020.12.001_bib31","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1002\/ana.20625","article-title":"Variable hypomethylation of D4Z4 in facioscapulohumeral muscular dystrophy","volume":"58","author":"van Overveld","year":"2005","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.omtm.2020.12.001_bib32","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1002\/humu.21091","article-title":"Common epigenetic changes of D4Z4 in contraction-dependent and contraction-independent FSHD","volume":"30","author":"de Greef","year":"2009","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.omtm.2020.12.001_bib33","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/1868-7083-6-23","article-title":"Identifying diagnostic DNA methylation profiles for facioscapulohumeral muscular dystrophy in blood and saliva using bisulfite sequencing","volume":"6","author":"Jones","year":"2014","journal-title":"Clin. Epigenetics"},{"key":"10.1016\/j.omtm.2020.12.001_bib34","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1093\/hmg\/ddu486","article-title":"Inter-individual differences in CpG methylation at D4Z4 correlate with clinical variability in FSHD1 and FSHD2","volume":"24","author":"Lemmers","year":"2015","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.omtm.2020.12.001_bib35","doi-asserted-by":"crossref","first-page":"6041","DOI":"10.3390\/ijms20236041","article-title":"Dead Cas Systems: Types, Principles, and Applications","volume":"20","author":"Brezgin","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.omtm.2020.12.001_bib36","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.cell.2016.09.006","article-title":"Inheritable Silencing of Endogenous Genes by Hit-and-Run Targeted Epigenetic Editing","volume":"167","author":"Amabile","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.omtm.2020.12.001_bib37","doi-asserted-by":"crossref","first-page":"9901","DOI":"10.1093\/nar\/gkx578","article-title":"dCas9-based epigenome editing suggests acquisition of histone methylation is not sufficient for target gene repression","volume":"45","author":"O\u2019Geen","year":"2017","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.omtm.2020.12.001_bib38","doi-asserted-by":"crossref","first-page":"4258","DOI":"10.1038\/s41467-019-12166-w","article-title":"Epigenome editing strategies for the functional annotation of CTCF insulators","volume":"10","author":"Tarjan","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omtm.2020.12.001_bib39","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1038\/sj.mt.6300027","article-title":"Design of tissue-specific regulatory cassettes for high-level rAAV-mediated expression in skeletal and cardiac muscle","volume":"15","author":"Salva","year":"2007","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2020.12.001_bib40","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/978-1-61737-982-6_1","article-title":"Design and testing of regulatory cassettes for optimal activity in skeletal and cardiac muscles","volume":"709","author":"Himeda","year":"2011","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.omtm.2020.12.001_bib41","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1126\/science.aad5177","article-title":"In\u00a0vivo gene editing in dystrophic mouse muscle and muscle stem cells","volume":"351","author":"Tabebordbar","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.omtm.2020.12.001_bib42","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1093\/nar\/gkw1112","article-title":"Efficient targeted DNA methylation with chimeric dCas9-Dnmt3a-Dnmt3L methyltransferase","volume":"45","author":"Stepper","year":"2017","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.omtm.2020.12.001_bib43","first-page":"3862","article-title":"Identification of a nonhistone chromosomal protein associated with heterochromatin in Drosophila melanogaster and its gene","volume":"6","author":"James","year":"1986","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.omtm.2020.12.001_bib44","doi-asserted-by":"crossref","first-page":"2555","DOI":"10.1128\/MCB.21.7.2555-2569.2001","article-title":"The hinge and chromo shadow domain impart distinct targeting of HP1-like proteins","volume":"21","author":"Smothers","year":"2001","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.omtm.2020.12.001_bib45","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.tcb.2014.01.002","article-title":"Mechanisms of functional promiscuity by HP1 proteins","volume":"24","author":"Canzio","year":"2014","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.omtm.2020.12.001_bib46","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1023\/A:1022923508198","article-title":"SU(VAR)3-9 is a conserved key function in heterochromatic gene silencing","volume":"117","author":"Schotta","year":"2003","journal-title":"Genetica"},{"key":"10.1016\/j.omtm.2020.12.001_bib47","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1038\/561","article-title":"Methylated DNA and MeCP2 recruit histone deacetylase to repress transcription","volume":"19","author":"Jones","year":"1998","journal-title":"Nat. Genet."},{"key":"10.1016\/j.omtm.2020.12.001_bib48","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1038\/30764","article-title":"Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex","volume":"393","author":"Nan","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.omtm.2020.12.001_bib49","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1139\/O08-115","article-title":"Recent advances in MeCP2 structure and function","volume":"87","author":"Hite","year":"2009","journal-title":"Biochem. Cell Biol."},{"key":"10.1016\/j.omtm.2020.12.001_bib50","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000094248","article-title":"Facioscapulohumeral muscular dystrophy and occurrence of heart arrhythmia","volume":"56","author":"Trevisan","year":"2006","journal-title":"Eur. Neurol."},{"key":"10.1016\/j.omtm.2020.12.001_bib51","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.nmd.2005.02.006","article-title":"Subclinical cardiac involvement in patients with facioscapulohumeral muscular dystrophy","volume":"15","author":"Galetta","year":"2005","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.omtm.2020.12.001_bib52","first-page":"2753","article-title":"Multiple regulatory elements contribute differentially to muscle creatine kinase enhancer activity in skeletal and cardiac muscle","volume":"13","author":"Amacher","year":"1993","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.omtm.2020.12.001_bib53","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1128\/MCB.16.4.1649","article-title":"Analysis of muscle creatine kinase gene regulatory elements in skeletal and cardiac muscles of transgenic mice","volume":"16","author":"Donoviel","year":"1996","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.omtm.2020.12.001_bib54","doi-asserted-by":"crossref","first-page":"1942","DOI":"10.1128\/MCB.00149-14","article-title":"Myogenic enhancers regulate expression of the facioscapulohumeral muscular dystrophy-associated DUX4 gene","volume":"34","author":"Himeda","year":"2014","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.omtm.2020.12.001_bib55","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.devcel.2011.11.013","article-title":"DUX4 activates germline genes, retroelements, and immune mediators: implications for facioscapulohumeral dystrophy","volume":"22","author":"Geng","year":"2012","journal-title":"Dev. Cell"},{"key":"10.1016\/j.omtm.2020.12.001_bib56","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1038\/35020506","article-title":"Regulation of chromatin structure by site-specific histone H3 methyltransferases","volume":"406","author":"Rea","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.omtm.2020.12.001_bib57","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1038\/nature16526","article-title":"High-fidelity CRISPR-Cas9 nucleases with no detectable genome-wide off-target effects","volume":"529","author":"Kleinstiver","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.omtm.2020.12.001_bib58","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/nature24268","article-title":"Enhanced proofreading governs CRISPR-Cas9 targeting accuracy","volume":"550","author":"Chen","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.omtm.2020.12.001_bib59","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/nature26155","article-title":"Evolved Cas9 variants with broad PAM compatibility and high DNA specificity","volume":"556","author":"Hu","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.omtm.2020.12.001_bib60","doi-asserted-by":"crossref","first-page":"20969","DOI":"10.1073\/pnas.1906843116","article-title":"Rationally engineered Staphylococcus aureus Cas9 nucleases with high genome-wide specificity","volume":"116","author":"Tan","year":"2019","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omtm.2020.12.001_bib61","first-page":"4419","article-title":"Model systems of DUX4 expression recapitulate the transcriptional profile of FSHD cells","volume":"25","author":"Jagannathan","year":"2016","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.omtm.2020.12.001_bib62","doi-asserted-by":"crossref","first-page":"e522","DOI":"10.3324\/haematol.2017.183152","article-title":"Transcriptional activities of DUX4 fusions in B-cell acute lymphoblastic leukemia","volume":"103","author":"Tanaka","year":"2018","journal-title":"Haematologica"},{"key":"10.1016\/j.omtm.2020.12.001_bib63","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/j.stem.2018.10.011","article-title":"Oncogenic Amplification of Zygotic Dux Factors in Regenerating p53-Deficient Muscle Stem Cells Defines a Molecular Cancer Subtype","volume":"23","author":"Preussner","year":"2018","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.omtm.2020.12.001_bib64","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.5966\/sctm.2015-0224","article-title":"A Human Pluripotent Stem Cell Model of Facioscapulohumeral Muscular Dystrophy-Affected Skeletal Muscles","volume":"5","author":"Caron","year":"2016","journal-title":"Stem Cells Transl. Med."},{"key":"10.1016\/j.omtm.2020.12.001_bib65","doi-asserted-by":"crossref","first-page":"3401","DOI":"10.1172\/JCI126366","article-title":"CIC-DUX4 oncoprotein drives sarcoma metastasis and tumorigenesis via distinct regulatory programs","volume":"129","author":"Okimoto","year":"2019","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.omtm.2020.12.001_bib66","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1038\/nmeth.3630","article-title":"Highly specific epigenome editing by CRISPR-Cas9 repressors for silencing of distal regulatory elements","volume":"12","author":"Thakore","year":"2015","journal-title":"Nat. Methods"},{"key":"10.1016\/j.omtm.2020.12.001_bib67","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.ymthe.2006.03.014","article-title":"Robust systemic transduction with AAV9 vectors in mice: efficient global cardiac gene transfer superior to that of AAV8","volume":"14","author":"Inagaki","year":"2006","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2020.12.001_bib68","doi-asserted-by":"crossref","first-page":"e1003947","DOI":"10.1371\/journal.pgen.1003947","article-title":"DUX4 binding to retroelements creates promoters that are active in FSHD muscle and testis","volume":"9","author":"Young","year":"2013","journal-title":"PLoS Genet."},{"key":"10.1016\/j.omtm.2020.12.001_bib69","doi-asserted-by":"crossref","first-page":"e0192657","DOI":"10.1371\/journal.pone.0192657","article-title":"A cre-inducible DUX4 transgenic mouse model for investigating facioscapulohumeral muscular dystrophy","volume":"13","author":"Jones","year":"2018","journal-title":"PLoS ONE"},{"key":"10.1016\/j.omtm.2020.12.001_bib70","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s13395-020-00227-4","article-title":"Transgenic mice expressing tunable levels of DUX4 develop characteristic facioscapulohumeral muscular dystrophy-like pathophysiology ranging in severity","volume":"10","author":"Jones","year":"2020","journal-title":"Skelet. Muscle"},{"key":"10.1016\/j.omtm.2020.12.001_bib71","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.cell.2015.12.035","article-title":"Biology and Applications of CRISPR Systems: Harnessing Nature\u2019s Toolbox for Genome Engineering","volume":"164","author":"Wright","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.omtm.2020.12.001_bib72","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.tips.2016.02.001","article-title":"Scalpel or Straitjacket: CRISPR\/Cas9 Approaches for Muscular Dystrophies","volume":"37","author":"Himeda","year":"2016","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.omtm.2020.12.001_bib73","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.jmb.2018.06.037","article-title":"A CRISPR-dCas Toolbox for Genetic Engineering and Synthetic Biology","volume":"431","author":"Xu","year":"2019","journal-title":"J.\u00a0Mol. Biol."},{"key":"10.1016\/j.omtm.2020.12.001_bib74","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.jbiotec.2019.05.306","article-title":"Active fusions of Cas9 orthologs","volume":"301","author":"Josipovi\u0107","year":"2019","journal-title":"J.\u00a0Biotechnol."},{"key":"10.1016\/j.omtm.2020.12.001_bib75","doi-asserted-by":"crossref","first-page":"113011","DOI":"10.1016\/j.expneurol.2019.113011","article-title":"Muscle xenografts reproduce key molecular features of facioscapulohumeral muscular dystrophy","volume":"320","author":"Mueller","year":"2019","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.omtm.2020.12.001_bib76","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s13395-016-0078-6","article-title":"Neuromuscular electrical stimulation promotes development in mice of mature human muscle from immortalized human myoblasts","volume":"6","author":"Sakellariou","year":"2016","journal-title":"Skelet. Muscle"},{"key":"10.1016\/j.omtm.2020.12.001_bib77","doi-asserted-by":"crossref","first-page":"2389","DOI":"10.1093\/nar\/gky1278","article-title":"R-loop formation by dCas9 is mutagenic in Saccharomyces cerevisiae","volume":"47","author":"Laughery","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.omtm.2020.12.001_bib78","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/s41594-017-0004-6","article-title":"APOBEC3 induces mutations during repair of CRISPR-Cas9-generated DNA breaks","volume":"25","author":"Lei","year":"2018","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.omtm.2020.12.001_bib79","doi-asserted-by":"crossref","first-page":"eaav4324","DOI":"10.1126\/sciadv.aav4324","article-title":"CRISPR-Cas9 corrects Duchenne muscular dystrophy exon 44 deletion mutations in mice and human cells","volume":"5","author":"Min","year":"2019","journal-title":"Sci. Adv."},{"key":"10.1016\/j.omtm.2020.12.001_bib80","doi-asserted-by":"crossref","first-page":"46494","DOI":"10.1074\/jbc.M308194200","article-title":"Differences in the function of three conserved E-boxes of the muscle creatine kinase gene in cultured myocytes and in transgenic mouse skeletal and cardiac muscle","volume":"278","author":"Nguyen","year":"2003","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.omtm.2020.12.001_bib81","doi-asserted-by":"crossref","first-page":"e10032","DOI":"10.7554\/eLife.10032","article-title":"Dopamine neurons projecting to the posterior striatum form an anatomically distinct subclass","volume":"4","author":"Menegas","year":"2015","journal-title":"eLife"},{"key":"10.1016\/j.omtm.2020.12.001_bib82","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/1741-7007-7-41","article-title":"Remodeling of the chromatin structure of the facioscapulohumeral muscular dystrophy (FSHD) locus and upregulation of FSHD-related gene 1 (FRG1) expression during human myogenic differentiation","volume":"7","author":"Bodega","year":"2009","journal-title":"BMC Biol."},{"key":"10.1016\/j.omtm.2020.12.001_bib83","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1038\/ejhg.2009.62","article-title":"Comprehensive expression analysis of FSHD candidate genes at the mRNA and protein level","volume":"17","author":"Klooster","year":"2009","journal-title":"Eur. J. Hum. Genet."},{"key":"10.1016\/j.omtm.2020.12.001_bib84","doi-asserted-by":"crossref","first-page":"e1003415","DOI":"10.1371\/journal.pgen.1003415","article-title":"Intrinsic epigenetic regulation of the D4Z4 macrosatellite repeat in a transgenic mouse model for FSHD","volume":"9","author":"Krom","year":"2013","journal-title":"PLoS Genet."},{"key":"10.1016\/j.omtm.2020.12.001_bib85","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1016\/j.cell.2011.10.040","article-title":"Polycomb-repressed genes have permissive enhancers that initiate reprogramming","volume":"147","author":"Taberlay","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.omtm.2020.12.001_bib86","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1038\/nature14299","article-title":"In\u00a0vivo genome editing using Staphylococcus aureus Cas9","volume":"520","author":"Ran","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.omtm.2020.12.001_bib87","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/nprot.2006.27","article-title":"Protocol for the fast chromatin immunoprecipitation (ChIP) method","volume":"1","author":"Nelson","year":"2006","journal-title":"Nat. Protoc."}],"container-title":["Molecular Therapy - Methods & Clinical Development"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2329050120302497?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2329050120302497?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T09:25:55Z","timestamp":1762421155000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2329050120302497"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":87,"alternative-id":["S2329050120302497"],"URL":"https:\/\/doi.org\/10.1016\/j.omtm.2020.12.001","relation":{},"ISSN":["2329-0501"],"issn-type":[{"value":"2329-0501","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeted epigenetic repression by CRISPR\/dSaCas9 suppresses pathogenic DUX4-fl expression in FSHD","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy - Methods & Clinical Development","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omtm.2020.12.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Author(s).","name":"copyright","label":"Copyright"}]}}